Lessons learned from young-onset diabetes in China

Current Diabetes Reports

Volumn 3, Issue 2, 2003, Pages 101-107

  Chan, Juliana C N ^a   Ng, Maggie C Y ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AUTOANTIBODY; BIOLOGICAL MARKER; C PEPTIDE; GLUCOKINASE; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; GROWTH HORMONE; HEMOGLOBIN A1C; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HYDROCORTISONE; INSULIN; LIPID; NORADRENALIN; NUCLEAR FACTOR I; PANCREAS ISLET CELL ANTIBODY;

ANGINA PECTORIS; AUTOIMMUNITY; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CHINA; CLINICAL FEATURE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; JUVENILE DIABETES MELLITUS; LEG AMPUTATION; METABOLIC SYNDROME X; MOLECULAR MECHANICS; MONOGENIC DISORDER; PATIENT CARE; PHENOTYPE; PREVALENCE; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; STROKE; AUTOIMMUNE DISEASE; DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE;

AGE OF ONSET; AUTOIMMUNE DISEASES; CHINA; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; PREVALENCE;

EID: 0037869123     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-003-0032-y     Document Type: Review

References (59)

1. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.
2. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes Care 1998, 21:1414-1431.
3. Ko GT, Li JK, Cheung AY, et al.: Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care 1999, 22:2096-2097.
4. Wat NM, Lam TH, Janus ED, Lam KS: Central obesity predicts the worsening of glycemia in southern Chinese. Int J Obes Rel Metab Disord 2001, 25:1789-1793.
5. Pan XR, Li GW, Hu YH, et al.: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20:537-544.
6. Cockram CS, Chan JC: The epidemiology of diabetes in the Western Pacific Region (excluding Japan). In Diabetes in the New Millennium. Edited by Turtle JR. Sydney: Pot Still Press; 1999:11-22.
7. Ko GT, Chan JC, Tsang LW, et al.: Outcomes of screening for diabetes in high-risk Hong Kong Chinese subjects. Diabetes Care 2000, 23:1290-1294.
8. Pan XR, Yang WY, Li GW, Liu J: Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997, 20:1664-1669.
9. Cockram CS, Woo J, Lau E, et al.: The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age. Diabetes Res Clin Pract 1993, 21:67-73.
10. Lam TH, Liu LJ, Janus ED, et al.: Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of type 2 diabetes mellitus and impaired glucose tolerance. Diabet Med 2000, 17:798-806.
11. Tan CE, Emmanuel SC, Tan BY, Jacob E: Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 1999, 22:241-247.
12. Rocchini AP: Childhood obesity and a diabetes epidemic. N Engl J Med 2002, 346:854-855.
13. Rosenbloom AL, Jow JR, Young RS, Winter WE: Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999, 22:345-354.
14. Sung RY, Tong PC, Yu CW, et al.: High prevalence of insulin resistance and metabolic syndrome in overweight/obese preadolescent Hong Kong Chinese children aged 9-12 years. Diabetes Care 2003, 26:250-251.
15. Yang Z, Wang K, Li T, et al.: Childhood diabetes in China: enormous variation by place and ethnic group. Diabetes Care 1998, 21:525-529.
16. Lee WR: The changing demography of diabetes mellitus in Singapore. Diabetes Res Clin Pract 2000, 50(suppl 2):S35-S39.
17. Leung SS, Lau JT, Tse LY, Oppenheimer SJ: Weight-for-age and weight-for-height references for Hong Kong children from birth to 18 years. J Paediatr Child Health 1996, 32:103-109.
18. Kitagawa T, Owada M, Urakami T, Yamauchi K: Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin Pediatr (Phila) 1998, 37:111-115.
19. Ko GT, Chan JC, Yeung VT, et al.: Antibodies to glutamic acid decarboxylase in young Chinese diabetic patients. Ann Clin Biochem 1998, 35:761-767.
20. Thai AC, Ng WY, Loke KY, et al.: Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Diabetologia 1997, 40:1425-1430.
21. Banerji MA, Chaiken RL, Huey H, et al.: GAD antibody negative NIDDM in adult Black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush Diabetes. Diabetes 1994, 43:741-745.
22. Tan KC, Mackay IR, Zimmet PZ, et al.: Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care 2000, 23:335-338.
23. Li JK, Chan JCN, Zimmet PZ, et al.: Young Chinese adults with new onset of diabetic ketoacidosis - clinical course, autoimmune status and progression of pancreatic beta-cell function. Diabet Med 2000, 17:295-298.
24. Bell GI, Polonsky KS: Diabetes mellitus and genetically programmed defects in beta cell function. Nature 2001, 414:788-791.
25. Chan JC, Cheung CK, Swaminathan R, et al.: Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgrad Med J 1993, 69:204-210.
26. Lee SC, Ko GT, Li JK, et al.: Factors predicting the age when type 2 diabetes is diagnosed in Hong Kong Chinese subjects. Diabetes Care 2001, 24:646-649.
27. Ng MC, Li JK, So WY, et al.: Nature or nurture - an insightful illustration from a Chinese family with hepatocyte nuclear factor-1 alpha diabetes (MODY3). Diabetologia 2000, 43:816-818.
28. Fajans SS, Bell GI, Polonsky KS: Molecular mechanisms and clinical pathophysiology of maturity onset diabetes of the young. N Engl J Med 2001, 345:971-980.
29. Ng MC, Cockburn BN, Lindner TH, et al.: Molecular genetics of diabetes mellitus in Chinese: identification of mutations in glucokinase and hepatocyte nuclear factor-1 alpha genes in patients with early-onset type 2 diabetes mellitus/MODY. Diabet Med 1999, 16:956-963.
30. Ng MC, Lee SC, Ko GT, et al.: Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity. Diabetes Care 2001, 24:663-671.
31. Xu JY, Chan V, Zhang WY, et al.: Mutations in the hepatocyte nuclear factor-1 alpha gene in Chinese MODY families: prevalence and functional analysis. Diabetologia 2002, 45:744-746.
32. Jap TS, Wu YC, Chiou JY, Kwok CF: A novel mutation in the hepatocyte nuclear factor-1 alpha/MODY3 gene in Chinese subjects with early-onset type 2 diabetes mellitus in Taiwan. Diabet Med 2000, 17:390-393.
33. Smith PR, Dronsfield MJ, Mijovic CH, et al.: The mitochondrial tRNA Leu(UUR) A to G 3243 mutation is associated with insulin dependent and non insulin dependent diabetes in a Chinese population. Diabet Med 1997, 14:1026-1031.
34. Xiang K, Wang Y, Wu S, et al.: Mitochondrial tRNA Leu(UUR) gene mutation diabetes mellitus in Chinese. Chin Med J (Engl) 1997, 110:372-378.
35. Ng MC, Yeung VT, Chow CC, et al.: Mitochondrial DNA A3243G mutation in patients with early- or late-onset type 2 diabetes mellitus in Hong Kong Chinese. Clin Endocrinol 2000, 52:557-564.
36. Lee SC, Hashim Y, Li JK, et al.: The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels. J Endocrinol 2001, 54:541-546.
37. Li JK, Chiu CK, Ng MC, et al.: Clustering of cardiovascular risk factors amongst siblings of Chinese young-onset diabetic patients [abstract]. Diabetes 2000, 49(suppl 1):A388.
38. Chan JC, Cheung JC, Lau EM, et al.: The metabolic syndrome in Hong Kong Chinese: the interrelationships among its components analyzed by structural equation modeling. Diabetes Care 1996, 19:953-959.
39. Lee ZS, Critchley JA, Ko GT, et al.: Obesity and cardiovascular risk factors in Hong Kong Chinese. Obes Rev 2002, 3:178-182.
40. Ko GT, Chan JC, Woo J, et al.: Simple anthropometric indexes and cardiovascular risk factors in Chinese. Int J Obes Relat Metab Disord 1997, 21:995-1001.
41. International Obesity Task Force: The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Edited by Inoue S, et al. Australia: World Health Organization, Western Pacific Region; 2000.
42. He M, Tan KC, Li ET, Kung AW: Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. Int J Obes Relat Metab Disord 2001, 25:748-752.
43. Ko GT, Tang J, Chan JC, et al.: Lower BMI cut off value to define BMI obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedence. Br J Nutr 2001, 85:239-242.
44. Lee ET, Lu M, Bennett PH, Keen H: Vascular disease in younger-onset diabetes: comparison of European, Asian and American Indian cohorts of the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001, 44(suppl 2):S78-S81.
45. Yokoyama H, Okudaira M, Otani T, et al.: High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis. Diabetes Care 1998, 21:1080-1085.
46. Chan JC, Cheung CK, Cheung MY, et al.: Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care 1995, 18:1013-1014.
47. Ko GT, Chan JC, Lau M, Cockram CS: Diabetic microangiopathic complications in young Chinese diabetic patients: a clinic-based cross-sectional study. J Diabetes Complications 1999, 13:300-306.
48. Chan JC, Tong PC, Critchley JA: The insulin resistance syndrome - mechanism of clustering of cardiovascular risk. In Seminars in Vascular Medicine. Edited by Yudkin JS, Stehouwer CDA. New York: Thieme Medical Publishers; 2002:45-57.
49. Mi J, Law C, Zhang KL, et al.: Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Ann Intern Med 2000, 132:253-260.
50. Lee ZS, Chan JC, Yeung VT, et al.: Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care 1999, 22:1450-1457.
51. Lee ZS, Critchley JA, Tomlinson B, et al.: Urinary epinephrine and norepinephrine interrelations with obesity, insulin and the metabolic syndrome in Hong Kong Chinese. Metabolism 2000, 50:135-143.
52. Pradhan AD, Manson JE, Rifai N, et al.: C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
53. Ferrannini E: Insulin resistance, iron, and the liver. Lancet 2000, 355:2181-2182.
54. Lao TT, Ho LF: Alpha-thalassaemia trait and gestational diabetes mellitus in Hong Kong. Diabetologia 2001, 44:966-971.
55. Tong PC, Ng MC, Ho CS, et al.: C reactive protein and insulin resistance in subjects with thalassemia minor and a family history of diabetes. Diabetes Care 2002, 25:1480-1481.
56. Tong PC, Lee ZS, Sea MM, et al.: The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes. Arch Intern Med 2002, 25:2428-2435.
57. Chan JC, Cockram CS: Diabetes in the Chinese population and its implications for health care. Diabetes Care 1997, 20:1785-1790.
58. Chan JC, Ng MC, Critchley JA, et al.: Diabetes mellitus-a special medical challenge from a Chinese perspective. Diabetes Res Clin Pract 2001, 54(suppl 1):19-27.
59. Chan WB, Chan JC, Chow CC, et al.: Glycemic control in type 2 diabetes: the impact of body weight, beta cell function and patient education. Q J Med 2000, 93:183-190.